Showa Inan General Hospital Report issue

Academic/Hospital Phase 4
Founded: Nagano Japan (2014)

Organization Overview

First Clinical Trial
2014
NCT00522093
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Akira Horiuchi | Showa Inan General Hospital